Hallucinogen Persisting Perception
Hallucinogen persisting perception disorder (HPPD) is a chronic disorder in which a person has non-psychotic flashbacks of visual hallucinations or distortions experienced during a previous hallucinogenic drug experience, usually lacking the same feelings of mental intoxication experienced before.
Cluster Number:
Wiki Number: W092
Diagnosis: Hallucinogen-Persisting Perception Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: non-psychotic flashbacks of visual hallucinations from previous drug expereinces; often visual snow as distracting lights
Progression:
Causes: prior use of hallucenogenic drugs, mescaline, MDMA (ecstasy)
Medications: cannabis worsens the effects; sedatives, sobriety from all psychoactive substances appears best
Therapies: talk therapy may help. 1 in 500,000 users may have chronic occurrences.
Youtube Video: Hallucinogen Persisting Perception Disorder
Amazon or Library Book: HPPD- My Experience with
Hallucinogen Persisting Perception Disorder
Click the book to link or order from Amazon.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controlsby Georg Leistenschneider on December 31, 2024
Classic psychedelics like LSD and psilocybin are showing promising effects in treating certain psychiatric disorders. Despite their low toxicity and lack of an addictive potential, in some individuals, psychedelics can be associated with persisting psychological harms. Hallucinogen Persisting Perception Disorder (HPPD) is one of those complications, a rare disorder characterized by enduring perceptual symptoms without impaired reality control. While the phenomenological aspects of HPPD have been...
- Adverse psychiatric effects of psychedelic drugs: a systematic review of case reportsby B Yildirim on November 20, 2024
CONCLUSIONS: Reliable descriptions of schizophrenia spectrum disorder and major affective disorder after psychedelic drug use disorder exist but are relatively uncommon. Flashbacks are sometimes but not always associated with psychiatric symptomatology, mainly anxiety or depression.
- Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysisby Jared T Hinkle on September 4, 2024
CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, classic psychedelics were generally well tolerated in clinical or research settings according to the existing literature, although SAEs did occur. These results provide estimates of common AE frequencies and indicate that certain catastrophic events reported in recreational or nonclinical contexts have yet to be reported in contemporary trial participants. Careful, ongoing, and improved pharmacovigilance is required to...
- Pharmacological Properties of Psychedelics with a Special Focus on Potential Harmsby Friederike Holze on July 30, 2024
Psychedelics are a group of substances within the heterogeneous class of hallucinogenic drugs. Via binding to the serotonin (5-HT) 2A receptor, psychedelics exert profound alterations in various mental domains, including sensation, cognition, emotions, and self-perception. Psychedelics comprise phenethylamines (e.g., mescaline), tryptamines (e.g., psilocybin), and ergolines (e.g., LSD). These drugs have been used recreationally for decades but have also regained attention as potential treatments...